Given Imaging's M2A to be Reimbursed in New York and New Jersey by Empire Medicare Services -- Also receives Medicare coverage in 5 additional states and territories

ATLANTA (June 12, 2002) -- Given Imaging, Inc. (NASDAQ: GIVN) announced today that Empire Medicare Services issued a coverage policy for reimbursement of capsule endoscopy for the small intestine. As a result of this announcement, Empire Medicare Services will offer capsule endoscopy reimbursement to those among its 5.4 million beneficiaries who may suffer from diseases of the small intestine within the noted indications.

"This is a very important milestone for NY/NJ Medicare", stated Dr. James Aisenberg of Mt. Sinai Hospital in New York. "It will now make this powerful diagnostic device for small bowel disorders available to a very large patient population."

Medicare coverage statements have been announced in 5 additional markets, by Palmetto GBA for South Carolina, Ohio, and West Virginia, and by Triple-S for Puerto Rico and The U.S. Virgin Islands.

In May, Capsule Endoscopy received a Medicare coverage statement from the National Heritage Insurance Co. in California and a non-Medicare coverage policy from Anthem Blue Cross and Blue Shield which covers eight states including Indiana, Kentucky, Ohio, Connecticut, New Hampshire, Colorado, Nevada and Maine.

"We are pleased to see growing momentum for coverage of the capsule endoscopy procedure by both public and private insurance entities," said Dr. Gavriel D. Meron, president and CEO of Given Imaging Ltd. "Following this announcement, formal reimbursement coverage statements from Medicare and non-Medicare payers will address a patient base of more than 20 million people in the United States."

This press release contains forward-looking statements, including projections about our business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, words such as "anticipates," "estimates," "expects," "intends," "plans," "believes," "intends" and words and terms of similar substance used in connection with any discussion of future operating or financial performance identify such forward-looking statements. Those forward-looking statements are not guarantees of future performance and actual results could differ materially from our current expectations as a result of numerous factors, including but not limited to the following: changes in regulatory environment, our success in implementing our sales, marketing and manufacturing plan, protection and validity of patents and other intellectual property rights, the impact of currency exchange rates, the effect of competition by other companies, the outcome of future litigation, the reimbursement policies for our product from healthcare payors, and other risks disclosed in our filings with the U.S. Securities Exchange Commission.

19.Sept.'03